Ledger.Open graph →
SEC Form D · filed March 10, 2021

DTx Pharma, Inc

Offering
$100.2M
Sold
$100.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Arthur Suckow · San Diego, CAExec · DirectorJeffrey Friedman · Chappaqua, NYExec · DirectorJohn Rundy · San Diego, CADirectorJeffrey Friedman · Chappaqua, NYExec · DirectorNiki Upper · San Diego, CAExecMatthew Hammond · TORONTO, Ontario, CanadaDirectorDaniel Becker · San Francisco, CADirectorTim Scott · San Diego, CADirectorAndrew Adams · Scottsdale, AZDirectorArthur Suckow · San Diego, CAExec · DirectorJohn Rundy · San Diego, CADirectorJeffrey Friedman · San Diego, CAExec · DirectorNiki Upper · San Diego, CAExecMatthew Hammond · Salt Lake City, X1DirectorDaniel Becker · San Diego, CADirectorTim Scott · San Diego, CADirectorAndrew Adams · BELLEVUE, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗